(Q42474675)
Statements
1 reference
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. (English)
1 reference
Chetana Basavaraj
1 reference
Patricia Sierra
1 reference
Jatteppanavar Shivu
1 reference
Ramakrishnan Melarkode
1 reference
Enrique Montero
1 reference
Pradip Nair
1 reference
1 October 2010
1 reference
1 reference
10
1 reference
7
1 reference
673-681
1 reference
Identifiers
1 reference
1 reference